Description
QUIDEL TRIAGE TOX DRUG SCREEN ANALYZER
First action · last action
2026-09-25 · 2026-09-25
Transactions
1
First transaction's obligation
$20,028
Base + all options value (sum of deltas)
$20,028
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-09-25+$20,028= $20,028
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-09-25 | +$20,028 | $20,028 | QUIDEL TRIAGE TOX DRUG SCREEN ANALYZER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F5TEGZ32EJ38)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0509 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $773,691 | FY2026 |
| 36C25526N0440 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $10,342 | FY2026 |
| 36C25526N0439 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $50,698 | FY2026 |
| 36C25526N0437 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,194 | FY2026 |
| 36C25526N0408 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $59,553 | FY2026 |
| 36C25526N0441 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $15,850 | FY2026 |
Other recipients under 6550 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026N0794 | ROCHE DIAGNOSTICS CORPORATION | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $200,000 | FY2026 |
| 36C25026N0788 | ROCHE DIAGNOSTICS CORPORATION | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $135,282 | FY2026 |
| 36C25026N0718 | ABBOTT LABORATORIES INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $212,150 | FY2026 |
| 36C25026N0778 | LEICA MICROSYSTEMS INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $120,282 | FY2026 |
| 36C25026F0645 | GOVERNMENT SCIENTIFIC SOURCE INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $53,963 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25026P1145_3600_-NONE-_-NONE- · retrieved 2026-09-27.